• No results found

[PDF] Top 20 FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLETS OF LAMIVUDINE BY 22 FACTORIAL DESIGN

Has 10000 "FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLETS OF LAMIVUDINE BY 22 FACTORIAL DESIGN" found on our website. Below are the top 20 most common "FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLETS OF LAMIVUDINE BY 22 FACTORIAL DESIGN".

FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLETS OF LAMIVUDINE BY 22 FACTORIAL DESIGN

FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLETS OF LAMIVUDINE BY 22 FACTORIAL DESIGN

... oral controlled release tablets of Lamivudine employing a combination of hydrophilic polymer, HPMC K 100M and hydrophobic polymer, ethyl cellulose using 2 2 factorial ...drug ... See full document

9

FORMULATION DESIGN AND CHARACTERIZATION OF MATRIX TABLETS OF LAMIVUDINEY.Naresh,ChandrasekharaRaoBaru,Vidyadhara.S,RLCSasidharDOWNLOAD/VIEW

FORMULATION DESIGN AND CHARACTERIZATION OF MATRIX TABLETS OF LAMIVUDINEY.Naresh,ChandrasekharaRaoBaru,Vidyadhara.S,RLCSasidharDOWNLOAD/VIEW

... drugs. Tablets are the most popular oral formulations available in the market and are preferred by patients and physicians ...[1]. Controlled release (CR) tablet formulations are preferred for such ... See full document

9

FORMULATION AND EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE EMPLOYING HPMC K4M AND SODIUM ALGINATE

FORMULATION AND EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE EMPLOYING HPMC K4M AND SODIUM ALGINATE

... CONCLUSION: Controlled release floating tablets of lamivudine formulated by using HPMC K4 M at a concentration of 40% w/w and sodium bicarbonate at 20% exhibited a floating lag time of less ... See full document

5

FORMULATION DESIGN AND EVALUATION OF CEPHALEXIN CONTROLLED RELEASE MATRIX TABLETS

FORMULATION DESIGN AND EVALUATION OF CEPHALEXIN CONTROLLED RELEASE MATRIX TABLETS

... the formulation at 40°C ± 2°C and 75% RH ± 5% RH was conducted for the 3 months, which includes the testing of parameters like identification of physical characters, identified by FTIR studies, dissolution profile ... See full document

12

Design and Evaluation of Controlled Onset Extended Release (Coer) Press-Coated Tablets for Chronotherapeutic Delivery of Propranolol Hydrochloride

Design and Evaluation of Controlled Onset Extended Release (Coer) Press-Coated Tablets for Chronotherapeutic Delivery of Propranolol Hydrochloride

... formulation design and in vitro/in vivo investigation of Once-daily propranolol extended-release tablet dosage form, it is composed of three formulation variables: the content of HPMC (X1); ... See full document

118

Design and Optimization of Controlled Release Felbamate Tablets by D-optimal Mixture Design: In vitro-in vivo Evaluation

Design and Optimization of Controlled Release Felbamate Tablets by D-optimal Mixture Design: In vitro-in vivo Evaluation

... of tablets and suspension have to be administered multiple times a day, leading to drawbacks such as poor patient compliance and poor control over therapy due to fluctuating plasma drug ...daily formulation ... See full document

11

FORMULATION DESIGN, DEVELOPMENT AND CHARACTERIZATION OF MATRIX TABLETS OF LAMIVUDINE BY USING NOVEL TECHNIQUE FOR CONTROLLED RELEASE

FORMULATION DESIGN, DEVELOPMENT AND CHARACTERIZATION OF MATRIX TABLETS OF LAMIVUDINE BY USING NOVEL TECHNIQUE FOR CONTROLLED RELEASE

... (3) Lamivudine requires multiple daily drug dosage in order to maintain adequate plasma ...making controlled release ...on Lamivudine ER formulations, some of them are, mucoadhesive ... See full document

13

FORMULATION DEVELOPMENT AND EVALUATION OF LAMOTRIGINE SUSTAINED RELEASE TABLETS USING 32 FACTORIAL DESIGN

FORMULATION DEVELOPMENT AND EVALUATION OF LAMOTRIGINE SUSTAINED RELEASE TABLETS USING 32 FACTORIAL DESIGN

... sustained release tablets were carried out in USP XXIII type-II dissolution test apparatus (Paddle type) using 900 ml of ...drug release by measuring the absorbance at 254 nm using UV Visible ... See full document

7

FORMULATION AND EVALUATION OF LAMIVUDINE AND TENOFOVIR DISPROXIL FUMARATE IR TABLETS

FORMULATION AND EVALUATION OF LAMIVUDINE AND TENOFOVIR DISPROXIL FUMARATE IR TABLETS

... metabolite, Lamivudine triphosphate ...monophosphate, Lamivudine is a synthetic nucleoside ...immediate release dosage form allows a manufacturer to extend market exclusivity, while offering patients ... See full document

5

FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC PUMP TABLETS FOR ZIDOVUDINE AND LAMIVUDINE COMBINATION USING FRUCTOSE AS OSMOGEN

FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC PUMP TABLETS FOR ZIDOVUDINE AND LAMIVUDINE COMBINATION USING FRUCTOSE AS OSMOGEN

... The in vitro dissolution 11 studies were carried out using USP apparatus type II (Lab India 8000) at 75 rpm. For the first 2 h the dissolution medium was 0.1N HCl (pH 1.2) and phosphate buffer pH 6.8 from 3-8 h (900 ml), ... See full document

10

DEVELOPMENT AND EVALUATION OF IRBESARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN

DEVELOPMENT AND EVALUATION OF IRBESARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN

... factorial design to achieve NLT 85% dissolution in 10 ...Irbesartan tablets as per 2 2 factorial design, βCD and Crospovidone are considered as the two ...2 factorial ... See full document

9

Formulation and Evaluation of Lamivudine Sustained Release Matrix Tablets Using Synthetic Polymers

Formulation and Evaluation of Lamivudine Sustained Release Matrix Tablets Using Synthetic Polymers

... delivery design for other ...oral controlled drug delivery systems (OCDDS) relay on diffusion, dissolution, or combination of both mechanisms, to release the drug in a controlled manner to the ... See full document

169

Formulation and Evaluation of Hydroxypropyl Methylcellulose-based Controlled Release Matrix Tablets for Theophylline

Formulation and Evaluation of Hydroxypropyl Methylcellulose-based Controlled Release Matrix Tablets for Theophylline

... no. 22 and then evaluated for angle of repose, bulk density, tapped density, bulkiness, compressibility index and hausner ...into tablets weighing 500 mg using 12 mm round flat faced punches in a rotary ... See full document

6

Formulation and In-vitro Evaluation of Matrix Controlled Lamivudine Tablets

Formulation and In-vitro Evaluation of Matrix Controlled Lamivudine Tablets

... all tablets are the most popular oral formulations available and preferred by the patients and physicians ...Hence, Controlled release (CR) tablet formulations are much desirable and preferred for ... See full document

7

In vivo evaluation of lamivudine extended release trilayer matrix tablets

In vivo evaluation of lamivudine extended release trilayer matrix tablets

... the design of dosage forms for oral controlled release administration, and hydrophilic polymers matrix systems are widely used because of their flexibility to provide a desirable drug release ... See full document

13

FORMULATION DEVELOPMENT OF VALSARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN

FORMULATION DEVELOPMENT OF VALSARTAN TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN

... mg) tablets were prepared by direct compression method as per the formula given in Table ...Micromeritic evaluation of the blends was made by determining angle of repose (θ) and compressibility index ... See full document

9

FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE

FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE

... Drug release studies: The drug release from the prepared controlled release floating tablets of lamivudine formulations were tested in 900ml of ...for lamivudine content ... See full document

7

Formulation and In Vitro Evaluation of Lamivudine and Zidovudine Controlled Release Bilayer Matrix Tablets.

Formulation and In Vitro Evaluation of Lamivudine and Zidovudine Controlled Release Bilayer Matrix Tablets.

... al., Controlled-release (CR) medications offer many clinical and convenience advantages for patients as compared to immediate-release (IR) ... See full document

155

FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FINASTERIDE

FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FINASTERIDE

... Pre formulation characterization of the pure drug was performed for comparing the data with different developed formulations (F1 to F12), obtained from the analysis of formulation of ... See full document

8

FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF MONTELUKAST SODIUM

FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF MONTELUKAST SODIUM

... prepared tablets: The results of physical evaluation of tablets were given in Table ...The tablets of different batches were found uniform with respect to hardness within the range of ... See full document

9

Show all 10000 documents...